Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inflammatory Bowel Syndrome clinical trials
1 of 2 indexed Inflammatory Bowel Syndrome trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Inflammatory Bowel Syndrome: 2 US clinical trials tracked, 1 recruiting.
Inflammatory Bowel Syndrome is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is American Laboratory Products Company, running 1 of these trials.
Enrollment posture brief
Registry condition inflammatory-bowel-syndrome
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Inflammatory Bowel Syndrome lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Inflammatory Bowel Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Inflammatory Bowel Syndrome is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
American Laboratory Products Company
NCT06810518
Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome
Oregon State University
NCT05482464
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Inflammatory Bowel Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Inflammatory Bowel Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Inflammatory Bowel Syndrome page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Inflammatory Bowel Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- American Laboratory Products Company sponsors the most Inflammatory Bowel Syndrome trials on record, review their full trial history before evaluating a specific study. See American Laboratory Products Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inflammatory Bowel Syndrome condition card totals 2 registered trials; most-linked intervention Casein glycomacropeptide (CGMP); top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.